Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. (Q38050961)

27 August 2017

title

Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. (English)

1 reference

27 August 2017

1 reference

Debbie S Gipson

2

0 references

author name string

Rebecca M Lombel

series ordinal

1

1 reference

27 August 2017

Elisabeth M Hodson

series ordinal

3

1 reference

27 August 2017

Kidney Disease: Improving Global Outcomes

series ordinal

4

1 reference

27 August 2017

publication date

3 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

28

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

415-426

1 reference

Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Management of childhood onset nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Going from evidence to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Long-term outcome of primary nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Alkylating agents and human spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Side effects of levamisole in children with nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Rituximab in refractory nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Fatal pulmonary fibrosis after rituximab administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Long-term results of two unconventional agents in steroid-dependent nephrotic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2310-X

Corticosteroid therapy for nephrotic syndrome in children

21 January 2018

1 reference

12 December 2020

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

12 December 2020

Non-corticosteroid treatment for nephrotic syndrome in children

1 reference

12 December 2020

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

12 December 2020

Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.

1 reference

12 December 2020

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

1 reference

12 December 2020

Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.

1 reference

12 December 2020

Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome

1 reference

12 December 2020

[The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children]

1 reference

12 December 2020

Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome

1 reference

12 December 2020

Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood

1 reference

12 December 2020

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

1 reference

12 December 2020

Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

12 December 2020

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

12 December 2020

Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage

1 reference

12 December 2020

Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome

1 reference

12 December 2020

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

12 December 2020

The nephrotic syndrome

1 reference

12 December 2020

Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial

1 reference

12 December 2020

Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?

1 reference

12 December 2020

Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.

1 reference

12 December 2020

Management of steroid sensitive nephrotic syndrome: revised guidelines.

1 reference

12 December 2020

Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A?

1 reference

12 December 2020

10.1007/S00467-012-2310-X

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1053568401

0 references

1 reference